Streetbeat News

Earnings

SBUX

Starbucks Corporation (NASDAQ:SBUX) is set to release its Q2 FY2024 earnings on April 30, 2024, with analysts forecasting an EPS of 79 cents, up from 74 cents the previous year, and revenue of $9.13 billion. The company's Board approved a quarterly dividend of 57 cents per share. Shares slightly rose by 0.1% to $88.33 recently. Analysts from Wedbush, Guggenheim, Citigroup, Stifel, and Wells Fargo have provided varied ratings and price targets for Starbucks, reflecting cautious optimism.

Portfolio Pulse from Avi Kapoor

April 30, 2024 | 2:25 pm

LLY

TSLA

Eli Lilly raised its guidance, indicating a positive outlook, while Tesla experienced a pullback in its stock price. Additionally, Treasury yields saw an increase, reflecting changes in the investment landscape.

Portfolio Pulse from Benzinga Newsdesk

April 30, 2024 | 2:24 pm

AAPL

GOOGL

META

MSFT

NVDA

QQQ

SPY

TSLA

Today's Market Clubhouse Morning Memo focuses on trade strategies for SPY, QQQ, AAPL, MSFT, NVDA, GOOGL, META, and TSLA, offering detailed analysis and price targets based on a proprietary formula. The memo highlights potential breakouts or reversals for these stocks and ETFs, advising traders to stay alert to market conditions. Significant economic data releases and post-market earnings from major companies are expected to contribute to market volatility. The memo is part of exclusive content provided to Market Clubhouse members, offering insights and real-time mentorship from pro trader RIPS.

Portfolio Pulse from RIPS

April 30, 2024 | 2:19 pm

THFF

First Financial (NASDAQ:THFF) reported Q1 2024 earnings of $0.93 per share, missing the consensus estimate of $0.98. Quarterly sales were $48.351M, below the $50.789M estimate, marking a 9.98% decrease from the previous year.

Portfolio Pulse from Benzinga Newsdesk

April 30, 2024 | 2:18 pm

Citigroup CEO Fraser reported at the annual meeting that consumer delinquency levels are now above pre-Covid levels, with the exception of mortgages. This indicates a shift in consumer financial health and could have implications for the bank's credit risk and financial performance.

Portfolio Pulse from Benzinga Newsdesk

April 30, 2024 | 2:18 pm

AGBA

AKLI

GMM

LICN

MCD

MED

VNCE

U.S. stocks traded lower, with the Dow Jones falling over 200 points. McDonald's reported mixed Q1 results, missing EPS estimates but beating sales forecasts. Akili, AGBA Group, and Global Mofy Metaverse saw significant stock increases, while Lichen China, Vince Holding, and Medifast experienced notable declines. Oil prices rose slightly, while gold and silver fell. European and Asian markets showed mixed results, with various economic indicators reported.

Portfolio Pulse from Avi Kapoor

April 30, 2024 | 2:17 pm

MMM

SOLV

3M Company (NYSE:MMM) shares rose after reporting better-than-expected Q1 2024 results, with slight sales decline but higher adjusted EPS and operating margin. The company spun off its healthcare business into Solventum Corporation (NYSE:SOLV), retaining a 19.9% stake. 3M plans to monetize this stake within five years and returned $835 million to shareholders via dividends. The company also settled a lawsuit with U.S. public water suppliers for up to $10.3 billion. 3M's fiscal 2024 outlook includes adjusted sales growth of (0.25%) to +1.75% and adjusted EPS of $6.80-$7.30.

Portfolio Pulse from Akanksha Bakshi

April 30, 2024 | 2:16 pm

THFF

First Financial (NASDAQ:THFF) reported its Q1 2024 earnings at $0.93 per share, missing the consensus estimate of $0.98 by 5.1%.

Portfolio Pulse from Benzinga Newsdesk

April 30, 2024 | 2:03 pm

UMBF

Analyst ratings for UMB Financial (NASDAQ:UMBF) show a mix of bullish and bearish perspectives with a recent average price target of $94.67, marking a 10.21% increase from the previous target. The company faces challenges in revenue growth, net margin, ROE, and ROA, indicating potential hurdles in profitability and asset utilization.

Portfolio Pulse from Benzinga Insights

April 30, 2024 | 2:00 pm

DCGO

In the last three months, 8 financial analysts have provided diverse ratings on DocGo (NASDAQ:DCGO), with a shift towards bullish sentiment. The average 12-month price target is now $9.56, down 16.87% from the previous target, reflecting adjustments due to market conditions and company performance. DocGo's financial performance shows strong growth and profitability, with a revenue growth rate of 83.16% and a net margin of 3.8%, outperforming industry averages.

Portfolio Pulse from Benzinga Insights

April 30, 2024 | 2:00 pm